We are live on ! Find out more
DC

Davenport & Co Portfolio holdings

AUM $20.4B
1-Year Est. Return 18.11%
This Fund
S&P 500
This Quarter Est. Return
+0.23%
1 Year Est. Return
+18.11%
3 Year Est. Return
+63.26%
5 Year Est. Return
+74.4%
10 Year Est. Return
+287.26%
AUM
$17.7B
AUM Growth
+$60.4M
Cap. Flow
+$209M
Cap. Flow %
1.18%
Top 10 Hldgs %
18.86%
Holding
1,213
New
72
Increased
562
Reduced
438
Closed
64

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$59.8M
2
NVO
Novo Nordisk
NVO
+$48.8M
3
UNH icon
UnitedHealth
UNH
+$46.4M
4
UBER icon
Uber
UBER
+$37M
5
SNY icon
Sanofi
SNY
+$33.8M

Sector Composition

Rank Sector Weight
1 Financials 16.48%
2 Technology 15.4%
3 Healthcare 11.21%
4 Consumer Discretionary 9.96%
5 Industrials 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOW icon
451
Dow Inc
DOW
$21.9B
$2.26M 0.01%
56,444
-25,723
-31% -$1.2M
CGCP icon
452
Capital Group Core Plus Income ETF
CGCP
$8.33B
$2.25M 0.01%
101,557
+12,007
+13% +$271K
GPIX icon
453
Goldman Sachs ETF Trust Goldman Sachs S&P 500 Premium Income ETF
GPIX
$4.9B
$2.24M 0.01%
45,299
+7,581
+20% +$377K
CRM icon
454
Salesforce
CRM
$151B
$2.23M 0.01%
6,679
+257
+4% +$82K
GQI icon
455
Natixis Gateway Quality Income ETF
GQI
$266M
$2.23M 0.01%
41,035
+2,791
+7% +$153K
MCO icon
456
Moody's
MCO
$82.8B
$2.21M 0.01%
4,667
+402
+9% +$192K
BND icon
457
Vanguard Total Bond Market
BND
$157B
$2.21M 0.01%
30,664
+1,056
+4% +$77.2K
PHM icon
458
Pultegroup
PHM
$24.1B
$2.2M 0.01%
20,218
+2,000
+11% +$260K
IONS icon
459
Ionis Pharmaceuticals
IONS
$8.6B
$2.19M 0.01%
62,740
-12,858
-17% -$481K
GAIN icon
460
Gladstone Investment Corp
GAIN
$643M
$2.18M 0.01%
164,722
-650
-0.4% -$8.88K
AWI icon
461
Armstrong World Industries
AWI
$7.38B
$2.18M 0.01%
15,405
-665
-4% -$97.7K
WEC icon
462
WEC Energy
WEC
$35.7B
$2.17M 0.01%
23,045
+1,064
+5% +$103K
VNQ icon
463
Vanguard Real Estate ETF
VNQ
$39.2B
$2.16M 0.01%
24,251
+1,248
+5% +$118K
JHMM icon
464
John Hancock Multifactor Mid Cap ETF
JHMM
$5.92B
$2.16M 0.01%
36,120
+4,929
+16% +$304K
BKNG icon
465
Booking.com
BKNG
$149B
$2.14M 0.01%
10,775
-175
-2% -$33.6K
TMO icon
466
Thermo Fisher Scientific
TMO
$213B
$2.14M 0.01%
4,106
-76
-2% -$41.8K
ET icon
467
Energy Transfer Partners
ET
$70.1B
$2.12M 0.01%
108,035
+367
+0.3% +$6.5K
CSL icon
468
Carlisle Companies
CSL
$14.3B
$2.11M 0.01%
5,732
-311
-5% -$136K
PPA icon
469
Invesco Aerospace & Defense ETF
PPA
$8.24B
$2.1M 0.01%
18,296
+146
+0.8% +$17.2K
INCM icon
470
Franklin Income Focus ETF
INCM
$1.69B
$2.09M 0.01%
80,193
+25,361
+46% +$682K
PPL
471
PPL Corp
PPL
$26.5B
$2.09M 0.01%
64,292
+2,775
+5% +$91.4K
GEV icon
472
GE Vernova
GEV
$264B
$2.08M 0.01%
6,317
-159
-2% -$49.7K
CDW icon
473
CDW
CDW
$18.9B
$2.06M 0.01%
11,901
+10,633
+839% +$2.07M
JPC icon
474
Nuveen Preferred & Income Opportunities Fund
JPC
$2.89B
$2.06M 0.01%
262,100
-5,370
-2% -$43.2K
GWW icon
475
W.W. Grainger
GWW
$65.3B
$2.05M 0.01%
1,941
+45
+2% +$50.7K

Similar funds

Davenport & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Davenport & Co held 1,213 positions worth $17.7B, up 0.34% from $17.6B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Davenport & Co's Q4 2024 filing shows 72 new, 562 increased, 438 reduced and 64 closed positions. Its largest new stake was Kirby Corp: 155,000 shares worth $16.4M. The largest sale was Walt Disney, an estimated $186M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Davenport & Co's largest Q4 2024 buy was Kirby Corp: 155,000 shares worth $16.4M.
  • Davenport & Co added most to Merck in Q4 2024, an estimated $59.8M increase.
  • Davenport & Co's biggest Q4 2024 reduction was Walt Disney, cutting an estimated $186M.
  • Davenport & Co fully exited Crown Holdings in Q4 2024, selling an estimated $2.69M.
  • Davenport & Co's ten largest holdings make up 19% of its $17.7B portfolio in Q4 2024.
  • Davenport & Co opened 72 new positions and closed 64 in Q4 2024.
  • Davenport & Co's portfolio value rose 0.34% quarter-over-quarter to $17.7B.

Based on Davenport & Co's 13F filing for Q4 2024, filed 24 Jan 2025.